Merit Medical Systems, Inc. (NASDAQ:MMSI) Short Interest Down 9.9% in September
Merit Medical Systems, Inc. (NASDAQ:MMSI) Short Interest Down 9.9% in September
Merit Medical Systems, Inc. (NASDAQ:MMSI – Get Rating) was the recipient of a large drop in short interest in the month of September. As of September 15th, there was short interest totalling 964,500 shares, a drop of 9.9% from the August 31st total of 1,070,000 shares. Approximately 1.7% of the company's shares are sold short. Based on an average trading volume of 353,700 shares, the short-interest ratio is presently 2.7 days.
優點醫療系統公司(納斯達克:MMSI-GET評級)是9月份空頭股數大幅下跌的接受者。截至9月15日,空頭股數共有96.45萬股,較8月31日的107萬股下降了9.9%。該公司約1.7%的股票被賣空。以平均成交量35.37萬股計算,目前短息比率為2.7天。
Wall Street Analyst Weigh In
華爾街分析師也加入進來
Several brokerages recently weighed in on MMSI. TheStreet raised shares of Merit Medical Systems from a "c+" rating to a "b-" rating in a research report on Friday, September 16th. Piper Sandler lowered their price target on shares of Merit Medical Systems from $75.00 to $70.00 in a report on Friday, July 1st. StockNews.com lowered shares of Merit Medical Systems from a "strong-buy" rating to a "buy" rating in a research note on Wednesday. Canaccord Genuity Group lifted their price objective on shares of Merit Medical Systems from $67.00 to $69.00 and gave the company a "buy" rating in a research note on Friday, September 2nd. Finally, Canaccord Genuity Group lifted their price objective on shares of Merit Medical Systems from $67.00 to $69.00 in a research note on Friday, September 2nd. One investment analyst has rated the stock with a hold rating and six have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $72.14.
幾家券商最近也加入了對MMSI的看法。華爾街在9月16日星期五的一份研究報告中將Merit Medical Systems的股票評級從“c+”上調至“b-”。派珀·桑德勒在7月1日星期五的一份報告中將他們對Merit Medical Systems的目標股價從75.00美元下調至70.00美元。在週三的一份研究報告中,StockNews.com將Merit Medical Systems的股票評級從“強力買入”下調至“買入”。Cancord Genuity Group在9月2日星期五的一份研究報告中將Merit Medical Systems的股票目標價從67.00美元上調至69.00美元,並給予該公司“買入”評級。最後,在9月2日星期五的一份研究報告中,Canaccel Genuity Group將Merit Medical Systems的股票目標價從67.00美元上調至69.00美元。一名投資分析師對該股的評級為持有,六名分析師對該公司股票的評級為買入。根據MarketBeat.com的數據,該公司的平均評級為“適度買入”,共識目標價為72.14美元。
Merit Medical Systems Stock Performance
優點醫療系統股票表現
Shares of NASDAQ:MMSI opened at $56.51 on Friday. The company has a market cap of $3.21 billion, a price-to-earnings ratio of 55.40, a price-to-earnings-growth ratio of 2.20 and a beta of 1.00. The company has a 50-day moving average price of $58.83 and a 200-day moving average price of $59.69. The company has a current ratio of 2.52, a quick ratio of 1.33 and a debt-to-equity ratio of 0.22. Merit Medical Systems has a 12 month low of $50.46 and a 12 month high of $73.44.
納斯達克:MMSI上週五開盤報56.51美元。該公司市值為32.1億美元,市盈率為55.40倍,市盈率為2.20倍,貝塔係數為1.00。該公司的50日移動均線價格為58.83美元,200日移動均線價格為59.69美元。該公司的流動比率為2.52,速動比率為1.33,債務權益比率為0.22。優點醫療系統公司的12個月低點為50.46美元,12個月高位為73.44美元。
Insiders Place Their Bets
內部人士下注
In other Merit Medical Systems news, COO Neil Peterson sold 4,000 shares of the stock in a transaction dated Monday, August 1st. The stock was sold at an average price of $58.10, for a total transaction of $232,400.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, COO Ronald Frost sold 20,000 shares of the firm's stock in a transaction dated Wednesday, August 10th. The stock was sold at an average price of $62.10, for a total value of $1,242,000.00. Following the completion of the sale, the chief operating officer now directly owns 15,144 shares in the company, valued at approximately $940,442.40. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, COO Neil Peterson sold 4,000 shares of the firm's stock in a transaction dated Monday, August 1st. The shares were sold at an average price of $58.10, for a total value of $232,400.00. The disclosure for this sale can be found here. In the last ninety days, insiders sold 26,436 shares of company stock worth $1,627,142. Company insiders own 3.80% of the company's stock.
在Merit Medical Systems的其他消息中,首席運營官尼爾·彼得森在8月1日星期一的交易中出售了4000股該公司股票。該股以58.10美元的平均價格出售,總成交金額為232,400.00美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的,該文件可以通過此超鏈接。在其他新聞方面,首席運營官羅納德·弗羅斯特在8月10日星期三的一筆交易中出售了2萬股該公司股票。這隻股票的平均售價為62.10美元,總價值為1242,000.00美元。出售完成後,首席運營官現在直接擁有公司15,144股,價值約940,442.40美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的,該文件可通過這個環節。此外,首席運營官尼爾·彼得森在一筆日期為8月1日星期一的交易中出售了4000股該公司股票。這些股票的平均價格為58.10美元,總價值為232,400.00美元。關於這次銷售的披露可以找到這裏。在過去的90天裏,內部人士賣出了26,436股公司股票,價值1,627,142美元。公司內部人士持有該公司3.80%的股份。
Institutional Investors Weigh In On Merit Medical Systems
機構投資者看好Merit醫療系統
A number of hedge funds and other institutional investors have recently bought and sold shares of MMSI. Lindbrook Capital LLC grew its holdings in shares of Merit Medical Systems by 148.4% during the second quarter. Lindbrook Capital LLC now owns 477 shares of the medical instruments supplier's stock valued at $26,000 after buying an additional 285 shares during the last quarter. Meeder Asset Management Inc. purchased a new stake in shares of Merit Medical Systems during the first quarter valued at approximately $29,000. Harel Insurance Investments & Financial Services Ltd. purchased a new stake in shares of Merit Medical Systems during the second quarter valued at approximately $37,000. Quantbot Technologies LP purchased a new stake in shares of Merit Medical Systems during the first quarter valued at approximately $43,000. Finally, First Horizon Advisors Inc. grew its holdings in shares of Merit Medical Systems by 56.2% during the second quarter. First Horizon Advisors Inc. now owns 1,287 shares of the medical instruments supplier's stock valued at $70,000 after buying an additional 463 shares during the last quarter. Hedge funds and other institutional investors own 94.52% of the company's stock.
一些對衝基金和其他機構投資者最近買賣了MMSI的股票。Lindbrook Capital LLC在第二季度增持了148.4%的Merit Medical Systems股票。Lindbrook Capital LLC現在持有這家醫療器械供應商477股股票,價值2.6萬美元,上個季度又購買了285股。Meeder資產管理公司在第一季度購買了價值約2.9萬美元的Merit醫療系統公司的新股份。哈雷爾保險投資和金融服務有限公司在第二季度購買了價值約3.7萬美元的Merit醫療系統公司的新股份。Quantbot Technologies LP在第一季度購買了價值約4.3萬美元的Merit醫療系統公司的新股份。最後,First Horizon Advisors Inc.在第二季度增持了56.2%的Merit Medical Systems股票。First Horizon Advisors Inc.現在持有這家醫療器械供應商1,287股股票,價值7萬美元,此前該公司在上個季度又購買了463股。對衝基金和其他機構投資者持有該公司94.52%的股票。
Merit Medical Systems Company Profile
優點醫療系統公司簡介
(Get Rating)
(獲取評級)
Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy.
優點醫療系統公司設計、開發、製造和營銷用於介入、診斷和治療程序的一次性醫療產品,主要用於心臟病學、放射學、腫瘤學、危重護理和內窺鏡檢查。該公司在心血管和內窺鏡兩個領域開展業務。
Further Reading
進一步閲讀
- Get a free copy of the StockNews.com research report on Merit Medical Systems (MMSI)
- EV Battery Maker Freyr Set For Major Global Expansion
- MarketBeat: Week in Review 9/26 – 9/30
- This Is A Memorable Time To Buy Into Micron Technology
- Declining Profits Challenge the CarMax Value Proposition
- Let Paychex Stock Work Hard For You
- 免費獲取StockNews.com關於Merit Medical Systems(MMSI)的研究報告
- 電動汽車電池製造商Freyr將在全球大舉擴張
- MarketBeat:回顧一週9/26-9/30
- 這是買入美光科技的難忘時刻
- 利潤下降對CarMax價值主張的挑戰
- 讓Paychex股票為您努力工作
Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.
接受新聞和評級的優點醫療系統每日-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Merit Medical Systems和相關公司的最新新聞和分析師評級的每日簡要摘要。